Results for tag: "Xarelto"

Xarelto is a hematological drug used to treat and prevent blood clots. It is a direct factor Xa inhibitor, meaning it works by blocking the action of factor Xa, a protein in the blood that helps form clots. Xarelto is used to reduce the risk of stroke and systemic embolism in people with non-valvular atrial fibrillation, to treat and prevent deep vein thrombosis and pulmonary embolism, and to reduce the risk of recurrent deep vein thrombosis and pulmonary embolism after initial treatment. It is also used to treat and prevent venous thromboembolism in people undergoing knee or hip replacement surgery. Xarelto is a widely used hematological drug, with a range of indications and benefits. It is generally well tolerated, with a low risk of bleeding. It is available in both oral and injectable forms, making it a convenient option for many patients. Companies in the Xarelto market include Bayer, Janssen Pharmaceuticals, and Johnson & Johnson. Show Less Read more